Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Alivira Animal Health Limited, is an unlisted public company incorporated on 30 September, 2013. It is classified as a public limited company and is located in Thane, Maharashtra. It's authorized share capital is INR 158.00 cr and the total paid-up capital is INR 47.78 cr.
Alivira Animal Health Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 93.66% over the previous year. At the same time, it's book networth has decreased by 0.71%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
-8.04%
-93.66%
-203.45%
-0.71%
39.65%
11.4%
-2.69
-9.04
-5.85
-5.45
-19.45
0.24
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(16)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Catalyst Trusteeship Limited
No. of Loans: 2
Total Amount : 720.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 55.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 30.5 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 30.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 15.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Kamal Kishore Sharma | 00209430 | 4 years |
| Managing Director | Sharat Pandurang Narasapur
Shareholder
|
02808651 | 8 years |
| Director | Rajaram Narayanan | 02977405 | 3 years |
| Director | Vijayalakshmi Vaithianathan | 09228935 | 3 years |
| Director | Vedprakash Shantalingappa Ragate | 10578409 | 1 years |
| Kmp | Saurav Bhala | <HIDDEN> | 1 years |
| Kmp | Nihar Ranjan Das | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| LUPIN PHARMACARE LIMITED |
Amalgamated
|
1.1 Cr | 1 | Maharashtra |
| TEMPLECRAFT REALTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLERIVIERE PROPERTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| SEQUENT SCIENTIFIC LIMITED |
Active
|
49.9 Cr | 4 | Maharashtra |
| TEMPLETREE PROPERTIES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| VIYASH LIFE SCIENCES PRIVATE LIMITED |
Active
|
334.4 Cr | 1 | Telangana |
| FAISA FINANCIAL P LTD |
Active
|
52.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| SYMED LABS LIMITED |
Active
|
93.0 L | 2 | Telangana |
| SHILPA MEDICARE LIMITED |
Active
|
9.8 Cr | 1 | Karnataka |
| ELYSIAN LIFE SCIENCES PRIVATE LIMITED |
Strike Off
|
11.2 Cr | 1 | Karnataka |
| SEQUENT ANTI BIOTICS PRIVATE LIMITED |
Strike Off
|
7.0 L | 1 | Karnataka |
| SEQUENT PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
4.0 L | 1 | Karnataka |
| R.L.FINE CHEM PRIVATE LIMITED |
Active
|
5.1 L | 1 | Karnataka |
| GENZYME INDIA PRIVATE LIMITED |
Amalgamated
|
9.2 Cr | 1 | Maharashtra |
| SANOFI ANIMAL HEALTH INDIA PRIVATE LIMITED |
Strike Off
|
4.2 Cr | 1 | Maharashtra |
| SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED |
Amalgamated
|
33.4 Cr | 1 | Maharashtra |
| SEQUENT RESEARCH LIMITED |
Active
|
4.4 Cr | 2 | Karnataka |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| ALIVIRA ANIMAL HEALTH LIMITED, IRELAND | Ireland | - | - |
The incorporation date of ALIVIRA ANIMAL HEALTH LIMITED is 30 September, 2013
The authorized share capital of ALIVIRA ANIMAL HEALTH LIMITED is INR ₹ 158.0 Cr.
The paid-up capital of ALIVIRA ANIMAL HEALTH LIMITED is INR ₹ 47.8 Cr.
The registered address of ALIVIRA ANIMAL HEALTH LIMITED is 301, 3rd Floor, Dosti Pinnacle, Plot No. E7 Road No. 22, Wagle Industrial Estate, Thane (W) Mumbai Thane Maharashtra - 400604
The CIN number of ALIVIRA ANIMAL HEALTH LIMITED is U74120MH2013PLC248708.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
